Key result
The frequency of protein C and protein S deficiencies in Japanese patients with deep venous thrombosis was 15.6 and 7.38 times higher than in the control population, respectively.
Why the study?
What is the frequency of natural coagulation inhibitor deficiencies in Japanese patients with DVT compared to normal subjects?
Case-Control (n=505)
What is the frequency of natural coagulation inhibitor deficiencies in Japanese patients with DVT compared to normal subjects?
Japanese patients with DVT have a significantly higher frequency of protein C and protein S deficiencies compared to the normal population, suggesting a need for routine screening.
Answers are grounded in this paper and cite their sources.
Japanese DVT patients had markedly higher protein C/S deficiency rates; leaves open whether screening improves outcomes in this population.
One hundred and thirteen consecutive Japanese patients with deep venous thrombosis (DVT) were studied for the incidences of antithrombin III (AT-III), protein C (PC) and protein S (PS) deficiencies, and the results were compared with those of normal subjects. Ten of the 392 normal Japanese subjects were found with PS deficiency (n = 8, 2.02%) or PC deficiency (n = 2, 0.5%). PS deficiencies comprised type I (1/8, 12.5%), type 11 (4/8, 50%), and type III (3/8, 37.5%). All PC deficiencies were type I. Among patients with DVT, 32 (28.3%) were deficient in AT-III, PC and PS. These patients consisted of two AT-III deficiency (1.77%), nine PC deficiency (7.96%), 20 PS deficiency (17.7%), and one combined deficiency of PC and PS (0.88%). Both of the patients with AT-III deficiency were classified as type II, all those with PC deficiency as type I, and those with PS deficiency as type I in 25% (5/20), type II in 55% (11/20) and type III in 20% (4/20). The frequency of PC and PS deficiencies in patients with DVT were 15.6 and 7.38 times the control population frequency, respectively, and this difference was statistically significant (P < 0.05). These data suggest that the Japanese population has a high frequency of PC and PS deficiencies. We recommend that PS activity should be measured for screening of thrombosis since type II deficiency accounted for approximately 50% of PS deficiency cases in both patients and the normal group in the Japanese.
No takes yet. Share an insight, caveat, or question.
Suehisa et al. (2001) conducted a case-control in Deep venous thrombosis (n=505). Deep venous thrombosis (DVT) vs. Normal subjects was evaluated on Frequency of antithrombin III, protein C, and protein S deficiencies (p=< 0.05). The frequency of protein C and protein S deficiencies in Japanese patients with deep venous thrombosis was 15.6 and 7.38 times higher than in the control population, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: